Keeping US biotech ahead of China could help patients with rare diseases: experts
The growth of China's biotech sector has been astonishing. Beijing is pumping money into the industry, supporting research efforts and…
health care industry
Novo Nordisk shares rise after launch of anti-obesity pill Wegovy
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, on January 15, 2026. George Frey…
Novo Nordisk CEO talks GLP-1 pill at JPMorgan conference
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
OpenAI acquires healthcare technology startup Torch
OpenAI has acquired healthcare technology startup Torch, the company announced Monday. OpenAI bought Torch for about $60 million, according to…
Thank you for your support, here's how to connect with us.
When Becky Quick announced the CNBC Cures initiative, our effort to raise awareness about rare diseases and improve the lives…
CNBC launches initiative to help 30 million Americans with rare diseases
Thirty million. It's a big number. Maybe not in the context of business news, where we typically talk about company…
What to expect from the pharmaceutical industry at the JPM conference
Heidi Overton, Novo Nordisk CEO Maziar “Mike” Doustdar, Eli Lilly CEO David Ricks and Commerce Secretary Howard Lutnick listen as…
Abivax Stock Rises to Become Top Biotech Acquisition Target
Europe's best-performing blue-chip stocks in 2025 are expected to be bought by a larger peer, in a deal analysts say…
Patient advocates urge US court to stop AFP's prescription operations
In a photo illustration, prescription medications are seen next to a bottle of pills on July 23, 2024 in New…
CNBC's Becky Quick details her daughter's journey into rare diseases
I've spent the last 25 years in front of the camera here at CNBC and people have come to know…